Could You Help Shape the Future of Alzheimer’s Research?

Research has played a vital role in improving our understanding of dementia and developing the treatments available today. Every advance in diagnosis, care and medication has been made possible because individuals and families chose to take part in research studies.

At Young At Heart ULO, we are often asked about opportunities to become involved in dementia research. Whilst we do not conduct research ourselves, we believe people should have access to information about studies that may be relevant to them. Taking part in research is a personal decision, but having clear information can help people decide whether they would like to learn more.

Recently, we were pleased to welcome Rachel Metcalfe from MAC Clinical Research to one of our dementia drop-in sessions. Rachel shared information about a new clinical trial currently recruiting participants with Alzheimer’s disease — and about her plans to deliver a future carers’ talk for our community. We thought it would be helpful to share details of the study with our wider community so that anyone who may be interested can explore the opportunity further.

What Is the Study Looking At?

The study is investigating an experimental medication being developed to treat psychosis associated with Alzheimer’s disease.

When people hear the term psychosis, they often think of severe mental illness. However, psychosis can also occur in some people living with Alzheimer’s disease.

Psychosis may involve hallucinations or delusions. Hallucinations occur when a person sees, hears, smells or feels something that is not actually present. Delusions are strongly held beliefs that are not based in reality. For example, a person may believe that someone is stealing from them, that a deceased relative is still alive, or that strangers are living in their home.

These experiences can be confusing, frightening and distressing for the person living with dementia. They can also be challenging for family members and carers who are trying to understand what the person is experiencing and how best to respond.

The research team are investigating whether a new medication may help reduce these symptoms. The study will also assess the medication’s safety, tolerability and how it behaves within the body.

Why Is Research Like This Important?

Alzheimer’s disease is the most common cause of dementia, affecting hundreds of thousands of people across the UK.

Whilst there are treatments available that may help manage some symptoms and, in some cases, slow progression, there is currently no cure. Researchers continue to explore new approaches that may improve quality of life and help address symptoms that can have a significant impact on daily living.

For some families, hallucinations and delusions can be among the most difficult symptoms to navigate. Research studies such as this help researchers understand whether new treatments may offer additional support in the future.

Even when a study does not produce the results researchers hoped for, it still contributes valuable knowledge that helps shape future research and improve our understanding of dementia.

Who May Be Eligible to Take Part?

According to MAC Clinical Research, people may be eligible for the study if they:

• Are aged between 50 and 85 years.
• Have a diagnosis of Alzheimer’s disease.
• Have a family member, friend or other study partner who has daily contact with them and can attend clinic visits.
• Are taking a stable dose of an acetylcholinesterase inhibitor (a commonly prescribed Alzheimer’s medication) for Alzheimer’s disease.
• Meet the study’s additional medical eligibility criteria.

The research team will assess each individual to determine whether the study is suitable for them.

What Would Participation Involve?

The study includes an initial screening visit to determine eligibility.

For those who qualify, participation may involve up to fifteen additional outpatient visits over approximately eight weeks, although the exact number of visits may vary depending on individual circumstances.

Anyone considering participation will be provided with detailed information about the study and will have the opportunity to ask questions before deciding whether to take part.

Importantly, expressing an interest in the study does not commit someone to participating. It simply allows the research team to provide more information and determine whether the study may be appropriate.

What Support Is Available?

Taking part in research can feel daunting, particularly for people living with dementia and those who support them.

The research team advises that reasonable travel expenses are covered and transport can be arranged where required. Participants may also receive reimbursement linked to completed study visits.

The involvement of a family member, friend or other study partner is recognised as an important part of the research process. This reflects the reality that dementia affects not only the individual living with the condition but also those who support them day to day.

Is Taking Part Right for Everyone?

Research participation is a personal choice.

Some people are interested because they want to contribute to future advances in dementia care. Others are curious about new treatments being investigated. Some decide that research is not the right option for them at this stage of their journey.

There is no right or wrong decision.

What matters is having access to accurate information, asking questions and taking the time needed to make an informed choice.

Interested in Learning More?

If you or someone you support has Alzheimer’s disease and experiences symptoms such as hallucinations or delusions, this study may be worth exploring further.

You can find more information and register your interest directly with MAC Clinical Research. Registering an interest does not commit you to taking part — it simply provides an opportunity to learn more about the study and discuss it with the research team.

Research relies on people choosing to share their time and take part in studies like this. Whether or not you decide to participate, staying informed about dementia research helps us better understand the condition and supports the development of future treatments and approaches to care.

A Note on Rachel’s Upcoming Carers’ Talk

Rachel Metcalfe from MAC Clinical Research has also been invited to deliver a future carers’ talk for our Young At Heart ULO community. We hope this will provide an opportunity for people living with dementia, carers, family members and professionals to learn more about dementia research and ask questions in an informal setting. Further details will be shared through our social media channels and newsletter once arrangements have been confirmed.

Editor’s Note

Young At Heart ULO CIC is sharing information about this research study as a community information resource. We are not involved in the design, delivery or management of the study and cannot advise on individual eligibility or suitability.

Participation in research is a personal decision. Anyone considering taking part is encouraged to speak directly with the research team, review the study information carefully and discuss any questions or concerns with healthcare professionals, family members or those involved in their support.

This article is based on information published by MAC Clinical Research at the time of writing. Readers should refer directly to the research team for the most up-to-date information about eligibility criteria, study procedures and potential risks or benefits.